Annual Research Expenditures
Nationally in Atmospheric Science & Meteorology Funding
NSF HERD Survey
Nationally in NIH Funding
Blue Ridge Institute for Medical Research
Universities Granted Utility Patents
National Academy of Inventors
OVPRP’s impact-focused research strategy is anchored in four key areas
Oklahoma faces some of the most persistent health challenges in the country, and no single discipline is going to solve them. Our health research strategy draws on the full breadth of team science, working alongside our clinical partners, to drive life-saving research across cancer, diabetes, neuroscience, maternal and pediatric health, and more.
Oklahoma sits at the center of some of the most complex and severe weather patterns on the planet. Our weather research strategy draws on the full strength of the National Weather Center and our atmospheric science expertise to lead innovation in forecasting, risk reduction, and community resilience.
Oklahoma is home to a long-standing, deeply embedded aerospace and defense ecosystem, and few places can move research from concept to application as quickly. Home to major federal installations, world-class sustainment and logistics capabilities, and a growing network of industry partners, OU is advancing innovation, workforce development, and operational readiness for the nation’s warfighters.
Oklahoma has a deep legacy in domestic energy, and few states are better equipped to shape what comes next. Our energy research strategy draws on that legacy to lead advances in subsurface energy systems, critical minerals, carbon management, grid resilience, and next-generation energy technologies.
Thanks to more than $5 million in funding through a National Institutes of Health initiative, the University of Oklahoma's College of Nursing will support four maternal health research projects over the next four years.
A University of Oklahoma physician-researcher recently received $2.9 million in funding from the National Cancer Institute to study whether RedHill Biopharma’s drug opaganib, given after CAR T-cell therapy, can help the immune cells fight cancer more effectively.
A protein called Miro1 found at elevated levels in the skeletal muscle of people with type 2 diabetes may contribute to insulin resistance, potentially making it a target for future treatments that help the body regulate blood sugar, according to a study published today in Nature Communications.
